• 'The numbers don't lie': Endoscopy to become more prominent among next generation of spine surgeons
  • Minnesota orthopedic group hit with $111M negligence verdict
  • Orthopedic patient's death highlights potential dangers of prior authorization
  • Spine surgeon killed in Oklahoma hospital shooting
  • Neurosurgeon accepted $3.3M in illegal payments to perform spine surgeries at hospital
  • Spine surgeon gets jail time for abusing patient during hospital visit
  • Providence to pay $22.7M to settle unnecessary spine surgery allegations
  • Texas spine surgeon defending himself from 'Dr. Death 2.0' allegations
  • 'They're on really thin ice': Why 1 insurer has drawn spine surgeons' ire
  • Orthopedic surgeon must face suit in patient's death
  • Spine surgeon 1 of 9 physician billionaires on Forbes' 2022 list
  • Connecticut hospital to appeal $12.5M verdict to family of patient who died after orthopedic surgery
  • 4 spine technologies that promised more than they delivered
  • Orthopedic surgeon's health system exit steeped in controversy
  • Terminated orthopedic surgeon contracts with another New York hospital
  • Texas spine surgeon sued by State Farm over 'unnecessary' procedures
  • 22 hospitals ranked top 25 orthopedic hospitals 3+ years in a row
  • Orthopedic surgeon convicted of battery at hospital
  • UArizona neurosurgery chair dies after motorcycle collision
  • America's largest independent practices by number of spine surgeons
  • Could Medtronic's spine business be the next medtech spinoff?
  • 41 'rising stars' in orthopedics
  • Idaho orthopedic surgeon arrested for alleged misconduct at practice
  • Neurosurgeon's startup hits $1.2B valuation
  • Orthopedic surgeon indicted in $10M telemedicine fraud scheme
  • Orthopedic surgeon salaries in the 5 best, worst states for healthcare
  • New Jersey hospital must pay neurosurgeons $24.3M, appeals court rules
  • Good news, bad news for orthopedic surgeons: 6 observations
  • Why private equity is bettering orthopedics, 3 physician leaders say
  • Florida hospital patients say they were injured during surgeries. Now a physician faces 350 lawsuits.
  • Texas spine surgeon's $11M verdict being appealed
  • A Rutgers physician accused of 'ghost surgeries' will return — but with fewer responsibilities
  • Top orthopedic hospital in every state: US News
  • Rothman Orthopaedics to become national brand, but no 'aspirations to go beyond US'
  • Sports medicine physician fired amid misconduct allegations involving patients
  • Orthopedic surgeon asking for misconduct charges to be dropped
  • Unnecessary spine cases spur class action lawsuit
  • Colorado Supreme Court rejects hospital's bid to enforce $229K spine surgery bill
  • Jury finds neurosurgeon largely responsible for paralysis, awards $15.5M in damages
  • Dr. Jon Yoon performs NHL's 4th disc replacement in 7 months
  • Could Medtronic's spine business be the next medtech spinoff?

    Could Medtronic's spine business be the next medtech spinoff?

    Alan Condon -  

    Four spinoff companies in the orthopedic medtech industry have been completed or announced in the past year, and analysts predict that Medtronic's spine business might soon follow suit.

    Spinoff companies typically take place when the parent company believes it will be lucrative to do so and usually result in increased returns for shareholders because the newly independent companies can better focus on their specific products or services.

    This year, Zimmer Biomet spun off its spine and dental businesses, and Johnson & Johnson is expected to divide into two separate companies — one focusing on medical devices and drugs and the other focusing on consumer health products — in 2023.

    Analysts from Needham & Co., an independent investment bank and asset management firm, suggested that Medtronic's leadership may also be considering a spinoff transaction, with its spine and diabetes businesses the most likely candidates, according to Benzinga.

    In the company's second-quarter earnings call in November, Medtronic CEO Geoff Martha said the executive committee was spending "a lot more time" looking at its portfolio and capital allocation.

    "Our new operating model is giving us line of sight into what is required to compete and win over the long-term in each of our businesses," Mr. Martha said. "As a result, we're looking at our portfolio with a more critical eye, with a focus on growth and creating shareholder value. I'd be surprised if there weren't changes over the coming fiscal year, but I don't know yet if they will be smaller or more significant."

    The company looks a lot different than it did 10 years ago, when former CEO Omar Ishrak said he saw no advantage in spinning off Medtronic's spine unit. 

    "[Medtronic] turned around its spine business, which has now had several years of at- or above-market growth. But since management isn't only considering underperforming assets, we still see potential for a spine spin-off," according to Needham analysts. "Given [Medtronic's] limited exposure to orthopedics outside of spine, we believe management might choose to spin off the spine business (including enabling technologies)."

    Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

    Featured Webinars

    Featured Podcast

    Featured Whitepapers